Heiniger L E, Smith A B, Olver I, Grimison P, Klein B, Wootten A, Abbott J-A M, Price M A, McJannett M, Tran B, Stockler M R, Gurney H, Butow P N
Psycho-oncology Co-operative Research Group (PoCoG), The University of Sydney, Sydney, NSW, Australia.
The Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Camperdown, NSW, Australia.
Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12698. Epub 2017 May 22.
e-TC is an online intervention designed to address common psychosocial concerns of testicular cancer survivors. It aims to reduce anxiety, depression and fear of cancer recurrence by providing evidence-based information and psychological intervention. This paper details the development and pilot testing of e-TC. During pilot testing, 25 men (with varying psychological profiles) who had completed treatment for testicular cancer, 6 months to 5 years ago (which had not recurred), used e-TC over a 10-week period and provided quantitative and qualitative feedback on the feasibility and acceptability of the programme. Six men also completed a qualitative interview to provide detailed feedback on their experiences using e-TC. Fourteen men (56%) completed at least 80% of the programme. Participants reported a high level of satisfaction with the programme. Men's limited time was a barrier to programme use and completion, and participants suggested that men with a more recent diagnosis and a higher level of distress may be more likely to engage with the programme. e-TC appears to be a feasible and acceptable online intervention for survivors of testicular cancer. Findings from this study are currently being used to refine e-TC and guide the design of a larger efficacy study.
电子睾丸癌支持项目（e-TC）是一项在线干预措施，旨在解决睾丸癌幸存者常见的心理社会问题。它旨在通过提供循证信息和心理干预，减轻焦虑、抑郁以及对癌症复发的恐惧。本文详细介绍了e-TC的开发和试点测试情况。在试点测试期间，25名在6个月至5年前完成睾丸癌治疗（且未复发）、心理状况各异的男性，在10周时间内使用了e-TC，并就该项目的可行性和可接受性提供了定量和定性反馈。6名男性还完成了一次定性访谈，以提供他们使用e-TC经历的详细反馈。14名男性（56%）完成了该项目至少80%的内容。参与者对该项目表示高度满意。男性时间有限是使用和完成该项目的一个障碍，参与者认为近期确诊且痛苦程度较高的男性可能更愿意参与该项目。e-TC似乎是一种对睾丸癌幸存者可行且可接受的在线干预措施。本研究的结果目前正用于完善e-TC，并指导一项更大规模疗效研究的设计。
